Passage Bio
1 follower
‌
Passage Bio is a genetic medicines company based in Philadelphia, PA that is developing a deep pipeline of adeno-associated virus (AAV) delivered therapeutics for the treatment of rare monogenic central nervous system disorders (CNS).
Industries
Headquarters
Employees
Links
Org chart
William Chou
President & CEO
William Chou
Collapse
Mark Forman
Chief Medical Officer
James M. Wilson
Chief Scientific Advisor
Edgar B. Cale
General Counsel & Corporate Secretary
Jiwen Zhang
VP, Regulatory Affairs
Samiah Al-Zaidy
VP, Clinical Development
Kathleen Borthwick
VP, Financial Planning & Analysis
Eden Fucci
VP, Manufacturing Operations
Tiffini Voss
VP, Clinical Development
Stuart Henderson
VP, Corporate Development & Investor Relations
Sue Browne
VP, Biology
Steve Krausert
Vice President, Supply Chain & Planning
Anne Marie Pierce
Finance Operations Specialist
Patricia Elsasser
Director Clinical Operations
Sneh Patel
Senior Scientist
Derek Kichula
Senior Director, Engineering & General Manager
Rich Mastropietro
Executive Director, IT
Rose Johnstone
Executive Director, Data Management
Chelsea Difebbo Ortiz
Executive Director, Patient Advocacy
Glen Kerker II
Director, Regulatory Operations
Similar companies
REVOLUTION Medicines
5 followers
MindMed
4 followers
Summit Therapeutics
4 followers
Seer
4 followers
Mersana Therapeutics
1 follower
Relay Therapeutics
1 follower
Delfi Diagnostics
1 follower
Thermo Fisher Scientific
150 followers
Biogen
111 followers
Regeneron
90 followers
Agilent Technologies
62 followers
Discover companies